Table 2.
OR (95% CI) | |||
---|---|---|---|
Participants | Crude | Model I | Model II |
All participants | 0.97 (0.95–0.98)*** | 0.98 (0.97–0.99)* | 0.98 (0.97–0.99)* |
Dietary niacin intake (mg/day) | |||
Q1 (≤14.95) | Ref. | Ref. | Ref. |
Q2 (14.95–19.65) | 0.82 (0.64–1.05) | 0.95 (0.73–1.23) | 0.94 (0.72–1.22) |
Q3 (19.65–25.63) | 0.65 (0.47–0.89) | 0.78 (0.56–1.10) | 0.78 (0.56–1.09) |
Q4 (>25.63) | 0.46 (0.34–0.63) | 0.63 (0.44–0.88) | 0.63 (0.45–0.89) |
P for trend | <0.001 | 0.036 | 0.047 |
Note: Crude: Unadjusted; Model I: Adjusted for age, race, PIR, education level, BMI, alcohol consumption, smoking; Model II: Adjusted for age, race, PIR, education level, BMI, alcohol consumption, smoking, diabetes, hypertension, white blood cell count, red blood cell count, mean platelet volume, systemic immune-inflammatory index.*P-value<0.05, ***P-value< 0.001.